See more : Neovasc Inc. (NVCN.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Blue Biofuels, Inc. (BIOF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Blue Biofuels, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- CE Software, Inc. (CESF) Income Statement Analysis – Financial Results
- Self Storage Group ASA (SSG.OL) Income Statement Analysis – Financial Results
- Inaba Denki Sangyo Co.,Ltd. (9934.T) Income Statement Analysis – Financial Results
- Lintes Technology Co., Ltd. (6715.TW) Income Statement Analysis – Financial Results
- Vergnet SA (ALVER.PA) Income Statement Analysis – Financial Results
Blue Biofuels, Inc. (BIOF)
About Blue Biofuels, Inc.
Blue Biofuels, Inc., through its subsidiaries, focuses on technologies in the renewable energy, biofuels, and bioplastics technologies sectors. The company develops Cellulose-to-Sugar (CTS 2.0), a mechanical/chemical dry process for converting cellulose material into sugar and lignin for use in the biofuels industry. It also has license for Vertimass Process to convert ethanol into bio-jet fuel. The company was formerly known as Alliance Bioenergy Plus, Inc. and changed its name to Blue Biofuels, Inc. in August 2021. Blue Biofuels, Inc. was incorporated in 2012 and is based in Palm Beach Gardens, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 60.00K | 0.00 | 134.32K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 216.79K | 138.46K | 131.72K | 40.12K | 0.00 | 34.80K | 0.00 | 73.85K | 233.76K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -216.79K | -138.46K | -131.72K | -40.12K | 60.00K | -34.80K | 134.32K | -73.85K | -233.76K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.85M | 2.35M | 1.10M | 763.16K | 797.86K | 619.97K | 736.75K | 19.51K | 27.64K | 0.97 | 0.00 | 0.00 |
| General & Administrative | 1.24M | 1.54M | 1.03M | 1.23M | 1.04M | 2.30M | 4.31M | 4.30M | 5.33M | 7.68M | 2.29M | 135.09 |
| Selling & Marketing | -121.61K | 0.00 | 0.00 | 0.00 | 0.00 | 3.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.12M | 1.54M | 1.03M | 1.23M | 1.04M | 2.35M | 4.31M | 4.30M | 5.33M | 7.68M | 2.29M | 135.09 |
| Other Expenses | 0.00 | 1.50K | 33.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -125.86K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.97M | 3.89M | 2.14M | 1.99M | 1.84M | 2.97M | 5.05M | 4.30M | 5.33M | 7.68M | 2.29M | 135.09 |
| Cost & Expenses | 3.19M | 3.89M | 2.14M | 1.99M | 1.84M | 3.01M | 5.05M | 4.30M | 5.33M | 7.68M | 2.29M | 135.09 |
| Interest Income | 0.00 | 29.41 | 33.77 | 190.19 | 0.00 | 1.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.93 |
| Interest Expense | 97.78K | 29.41K | 33.77K | 190.19K | 0.00 | 0.00 | 902.92K | 1.28M | 189.39K | 11.15K | 12.03K | 0.00 |
| Depreciation & Amortization | 216.79K | 138.46K | 131.72K | 40.12K | 31.38K | 34.80K | 85.46K | 73.85K | 233.76K | 13.04K | 5.90K | 135.09 |
| EBITDA | -2.74M | -3.79M | -2.01M | -1.95M | 1.04M | -7.89M | -9.27M | -4.38M | -5.28M | -8.01M | -2.29M | -4.93 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2,908.83% | 0.00% | -3,739.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -3.19M | -3.93M | -2.17M | -1.99M | -1.78M | -3.01M | -4.91M | -4.30M | -5.33M | -7.68M | -2.29M | -135.09 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2,961.13% | 0.00% | -3,658.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 134.56K | -27.91K | 32.56K | -190.19K | 2.78M | -6.41M | -5.35M | -5.18M | -495.61K | -357.80K | -12.03K | -4.93 |
| Income Before Tax | -3.06M | -3.96M | -2.14M | -2.18M | 1.01M | -9.42M | -10.26M | -9.48M | -5.83M | -7.90M | -2.30M | -140.01 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 1,675.18% | 0.00% | -7,638.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.06K | 33.77K | 190.19K | -140.48K | 2.00 | 2.40K | -708.03K | -981.97K | 2.04M | 12.03K | -4.93 |
| Net Income | -3.06M | -3.96M | -2.17M | -2.37M | 1.01M | -9.42M | -10.26M | -8.77M | -4.84M | -9.94M | -2.30M | -140.01 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 1,675.18% | 0.00% | -7,640.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.01 | -0.07 | -0.13 | -0.15 | -0.12 | -0.27 | -0.11 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | 0.01 | -0.07 | -0.13 | -0.15 | -0.12 | -0.27 | -0.11 | -0.01 |
| Weighted Avg Shares Out | 299.95M | 278.83M | 269.64M | 229.88M | 166.07M | 137.56M | 77.60M | 57.62M | 38.99M | 37.03M | 20.27M | 19.31K |
| Weighted Avg Shares Out (Dil) | 299.95M | 278.83M | 269.64M | 229.88M | 166.07M | 137.56M | 77.60M | 57.62M | 38.99M | 37.03M | 20.27M | 19.31K |
Blue Biofuels Inches Closer To The Commercialization Of Its Patented CTS 2.0 Technology
Source: https://incomestatements.info
Category: Stock Reports